Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |